New research reveals that Gαi3 is overexpressed in bladder cancer and promotes tumour growth via the Akt-mTOR pathway, highlighting its potential as a therapeutic target.

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 pounds, and a lifelong ...

Bladder cancer predominantly affects older individuals, with a median diagnosis age of 73. The standard care involves trans-urethral resection of the bladder tumor (TURBT), but up to 70% of NMIBC ...

The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate cancer, respectively. The United States Food and Drug Administration's ...

Surgeons in the US have performed a 'miracle' bladder transplant for the first time — giving hope to thousands of patients living with deadly organ failure. The first ever patient to undergo ...

The recipient of the innovative procedure was Oscar Larrainzar, 41, a father of four who had a large portion of his bladder removed due to cancer several years ago, the University of California ...

AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladder ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from ...